Header Logo
Keywords
Last Name
Institution
Announcement

You can now add alternative names! Click here to add other names that you've published under.

R3500-AD-1805 A Phase 2B, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Dose-Ranging Study Investigating the Efficacy, Safety, and Pharmacokinetic Profiles of REGN3500 229151


Collapse Overview 
Collapse sponsor award id
R3500-AD-1805


Collapse Biography 

Collapse Time 
Collapse start date
2019-09-20